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SUMMARY
Previous studies have shown that adenophostin A is a potent initiator of the activation of store-
operated Ca2+ channels (SOCs) in rat hepatocytes, and have suggested that, of the two subtypes
of inositol trisphosphate (Ins(1,4,5)P3) receptor predominantly present in rat hepatocytes (types 1
and 2 (Ins(1,4,5)P3R1 and Ins(1,4,5)P3R2)), Ins(1,4,5)P3R1s are required for SOC activation.  We
compared the abilities of Ins(1,4,6)P3 (higher apparent affinity for Ins(1,4,5)P3R1) and
Ins(1,3,6)P3 and Ins(1,2,4,5)P4 (higher apparent affinities for Ins(1,4,5)P3R2) to activate SOCs.
The Ins(1,4,5)P3 analogues were microinjected into single cells together with fura-2, and dose-
response curves for the activation of Ca2+ inflow and Ca2+ release from intracellular stores
obtained for each analogue.  The concentration of Ins(1,4,6)P3 which gave half-maximal
stimulation of Ca2+ inflow was substantially lower than that which gave half-maximal
stimulation of Ca2+ release.  By contrast, for Ins(1,3,6)P3 and Ins(1,2,4,5)P3, the concentration
which gave half-maximal stimulation of Ca2+ inflow was substantially higher than that which
gave half-maximal stimulation of Ca2+ release.  The distribution of Ins(1,4,5)P3R1 and
Ins(1,4,5)P3R2 in rat hepatocytes cultured under the same conditions as those employed for the
measurement of Ca2+ inflow and release was determined by immunofluorescence.
Ins(1,4,5)P3R1s were found predominantly at the cell periphery whereas Ins(1,4,5)P3R2s were
found at the cell periphery, the cell interior and nucleus.  It is concluded that the idea that a small
region of the ER enriched in Ins(1,4,5)P3R1 is required for the activation of SOCs is consistent
with the present results for hepatocytes.
Keywords:  Store-operated Ca2+ channels, endoplasmic reticulum, inositol trisphosphate
receptors.
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INTRODUCTION
Store-operated Ca2+ channels (SOCs) in the plasma membrane are required for regulation of the
cytoplasmic free Ca2+ concentration ([Ca2+]cyt) and re-filling the endoplasmic reticulum (ER)
Ca2+ stores in hepatocytes and in other non-excitable cells, and in some excitable cells [1,2].
Several studies have shown that SOCs are required for the maintenance of agonist-induced
oscillations in [Ca2+]cyt [3,4] and there is evidence that SOCs are more effective in re-filling the
ER than non-selective cation channels [5].  The activation of SOCs is initiated by a decrease in
the concentration of Ca2+ in the ER induced by the action of inositol 1,4,5-trisphosphate
(Ins(1,4,5)P3) at Ins(1,4,5)P3 receptors (Ins(1,4,5)P3R) and by Ca
2+ at ryanodine receptors [1,2].
There is some evidence which suggests there may be a direct interaction (conformational
coupling) between some Ins(1,4,5)P3Rs and some putative SOCs or other types of plasma
membrane Ca2+ channels (reviewed in [1,2]).  Evidence that the activation of SOCs involves, or
requires, a specific region of the ER close to the plasma membrane in the vicinity of SOCs [6-9]
and/or continuity of the whole ER [10,11] has been reported.  While there have been numerous
experiments designed to determine the relationship between the degree to which Ca2+ in the ER
is decreased and the activation of SOCs, and the location of this decrease in ER Ca2+ [12,13], no
clear answers have so far been obtained.
Rat hepatocytes in situ are polarised epithelial cells with clearly-defined canalicular, basal and
basolateral membrane regions (reviewed in [14]).  Freshly-isolated rat hepatocytes lose much of
this polarity but after culture for a few hours begin to regain some polarity [15].  Normal rat
hepatocytes possess predominantly Ins(1,4,5)P3R1 and Ins(1,4,5)P3R2 with very little type 3
Ins(1,4,5)P3 receptor [16,17].  Ins(1,4,5)P3R2 predominate, and may be responsible for the
generation of [Ca2+]cyt waves emanating from the canalicular region [17].  There is evidence that
Ins(1,4,5)P3R1s are associated with a subregion of the ER which is close to the plasma
membrane and attached to the peripheral F-actin [18,19].
The results of previous studies with rat hepatocytes, which employed adenophostin A, an
Ins(1,4,5)P3 analogue with a very high affinity for Ins(1,4,5)P3R, 2-hydroxyethyl-α- D-
glucopyranoside  2,3',4'-trisphosphate (Glc(2,3',4')P3), and an antibody against Ins(1,4,5)P3R1
which inhibits Ins(1,4,5)P3R function, suggested that a subregion of the ER and the
Ins(1,4,5)P3R1 are both required for the activation of SOCs [9].  Adenophostin A has been used
to investigate the role of Ins(1,4,5)P3R and the ER in the mechanism of activation of SOCs in
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several other cell types [7,20] leading, in some studies, to the conclusion that a small sub-region
of the ER is required for SOC activation [7].
The aim of the present studies was to test further the roles of Ins(1,4,5)P3R1 and
Ins(1,4,5)P3R2 in the activation of SOCs in rat hepatocytes.  This has been done using
Ins(1,4,5)P3 analogues with different apparent affinities for Ins(1,4,5)P3R1 and Ins(1,4,5)P3R2
[21] to initiate intracellular Ca2+ release and Ca2+ inflow.  The intracellular locations of
Ins(1,4,5)P3R1 and Ins(1,4,5)P3R2 under the same primary cell culture conditions as those
employed for the measurement of Ca2+ inflow and release were also determined by
immunofluorescence.  The results provide evidence which indicates that a region of the ER (or
another intracellular Ca2+ store) which is enriched in Ins(1,4,5)P3R1 is involved in the activation
of SOCs.
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D-myo-Ins(1,3,6)P3 [22], D-myo-Ins(1,4,6)P3 [23], and D-myo-Ins(1,2,4,5)P4 [24] were
synthesised as described previously.  D-myo-2-Deoxy-Ins(1,4,5)P3 (AM Riley and BVL Potter
unpublished) was synthesized from D-3,6-di-O-benzyl-4,5-O-(2,3-dimethoxybutane-2,3-diyl)-
myo-inositol [25].  All ligands were prepared as their tri-ethylammonium salts and were
homogenous by routine spectroscopic methods.  The lyophilised form of each Ins(1,4,5)P3
analogue was reconstituted in water, washed through 0.5 ml Chelex-100 resin (to replace the tri-
ethylammonium cation with Na+) and again lyophilised.  Stock solutions were prepared by
dissolving the lyophilised Ins(1,4,5)P3 analogue in 125 mM KCl.  Monoclonal antibodies
KM1112 and KM1083 specific for Ins(1,4,5)P3R1 and Ins(1,4,5)P3R2, respectively, [26] were
kindly provided by Professor K Mikoshiba, University of Tokyo.  Horseradish peroxidase-
conjugated goat anti-mouse IgG was from Sigma.  Nitrocellulose and PVDF membranes and
ECL detection reagents were provided by Amersham.  SaOS-2 human osteosarcoma cells
(American Type Culture Collection (ATCC), Rockville, MD, USA) were kindly provided by Dr
T.J. McCann, Babraham Institute, Cambridgeshire, UK, and L15 mouse fibroblasts [27] by
Professor K. Mikoshiba, University of Tokyo, Japan.  SaOS-2 cells [28] and L15 mouse
fibroblasts [29] were cultured as described previously.
Isolation of hepatocytes and measurement of the cytoplasmic free Ca2+ concentration
([Ca2+]c)
The isolation of hepatocytes from Hooded Wistar rats, attachment of hepatocytes to collagen-
coated coverslips, the microinjection of fura-2 and Ins(1,4,5)P3 analogues and measurement of
the fluorescence of single hepatocytes loaded with fura-2 (using a ratiometric technique) were
carried out as described previously [9].  Changes in Ca2+ concentration are expressed as changes
in the fluorescence ratio (F340nm/F380 nm).  The dilution factor for the microinjection of agents to
hepatocytes was determined to be 1:75 [9] and was used to estimate the intracellular
concentrations of the Ins(1,4,5)P3 analogues microinjected into hepatocytes.
For estimates of the amounts of Ca2+ released from intracellular stores and rates of Ca2+
inflow, hepatocytes attached to collagen-coated coverslips were microinjected with fura-2
together with a given Ins(1,4,5)P3 analogue, incubated for 10 min (to allow the cells to re-seal
[9]), transferred to a medium containing no added Ca2+, and the fluorescence ratios measured.
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Rates of Ca2+ inflow in single hepatocytes were estimated following the addition of extracellular
Ca2+ (Ca2+o) to cells incubated in the absence of added Ca
2+
o (the “Ca
2+ add-back” protocol) [9]
from measurement of the initial rate of the Ca2+-induced increase in [Ca2+]cyt (expressed as
change in fluorescent ratio units per min).  Since the amount of Ca2+ which accumulates in the
cytoplasmic space in a Ca2+ add-back protocol depends on both the rate of inflow across the
plasma membrane and the rate of removal from the cytoplasmic space by transport into
intracellular stores and the extracellular space, the initial rate of increase in [Ca2+]cyt is a more
accurate reflection of the rate of Ca2+ inflow through SOCs than the value of the subsequent
plateau in [Ca2+]cyt (underlying assumptions discussed in [30]).
To estimate the amount of Ca2+ released from intracellular stores by a given Ins(1,4,5)P3
analogue, vasopressin (40 nM) was added to cells loaded with the Ins(1,4,5)P3 analogue plus
fura-2, or with fura-2 alone.  The amount of Ca2+ released by the Ins(1,4,5)P3 analogue was
calculated as the difference between the vasopressin-induced release of Ca2+ measured in the
absence and presence of the Ins(1,4,5)P3 analogue.  It has previously been shown, using EGTA
to chelate extracellular Ca2+, that the rapid increase in [Ca2+]cyt induced by vasopressin in the
presence of extracellular Ca2+ reflects the release of Ca2+ from intracellular stores with little
contribution from Ca2+ inflow across the plasma membrane [9].  This was confirmed in the
present series of experiments by measuring vasopressin-induced Ca2+ release (the height of the
vasopressin-induced peak of [Ca2+]cyt) in the presence of Ca
2+
o (1.5 mM) and in the presence of
both Ca2+o and EGTA (2 mM).  Experiments were performed with cells microinjected with fura-
2 plus Ins(1,4,6)P3 (10 µM), Ins(1,2,4,5)P4 (70 µM) and Ins(1,3,6)P3 (110 µM).  For each
analogue there was no significant difference in the amount of Ca2+ released in response to
vasopressin (40 nM) measured in the presence and absence of EGTA.  The amounts of Ca2+
release induced by vasopressin were 0.28 ± 0.02 and 0.36 ± 0.04 (EGTA); 0.52 ± 0.05 and 0.51
± 0.05 (EGTA); and 0.58 ± 0.04 and 0.53 ± 0.03 (EGTA) (means ± SEM, n= 8-15) for cells
containing Ins(1,4,6)P3, Ins(1,2,4,5)P4, and Ins(1,3,6)P3, respectively.
Western blot analysis
Tissue preparation, protein assays, SDS gels, and semi-dry blotting were performed essentially
as described previously [29].  SDS-minigels (6%) were run using the Biorad Immunoblot assay
kit.  Standard homogenisation, Western blotting and transfer buffers were used throughout, and
either nitrocellulose or PVDF membranes were used for immunoblotting.  Bands of
Ins(1,4,5)P3R1 and Ins(1,4,5)P3R2 were detected using mouse monoclonal anti-Ins(1,4,5)P3R1
KM1112 or mouse monoclonal anti-Ins(1,4,5)P3R2 KM1083 [26], horse anti-mouse IgG
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conjugated to Cy3 as secondary antibody and ECL detection.  “SeeBlue” pre-stained standards
(4-250 kDa, Novex) were used as molecular weight markers.  On 6% SDS-minigels, the myosin
standard (250 kDa) ran very close to the Ins(1,4,5)P3R1 and Ins(1,4,5)P3R2.
Immunolocalisation of Ins(1,4,5)P3R1 and Ins(1,4,5)P3R2
Rat hepatocytes grown on collagen-coated coverslips were rinsed with PBS and fixed with 4%
(w/v) paraformaldehyde in PBS for 30 min, rinsed with PBS, then permeabilised with 0.1% (v/v)
Triton X-100 in PBS for 10 min at room temperature.  Cells were again rinsed with PBS,
blocked with 10% (w/v) fetal bovine serum in PBS for 1 h at room temperature, washed with
PBS containing 0.05% (v/v) Tween-20 (PBS-T), and incubated overnight at 4°C with either
mouse monoclonal anti-Ins(1,4,5)P3R1 KM1112 or mouse monoclonal anti-Ins(1,4,5)P3R2
KM1083 [26].  The cells were then washed with PBS-T and incubated for 1 h at room
temperature in the dark with the secondary antibody, Cy3-conjugated anti-mouse IgG, at 1:1000
dilution in PBS-T containing 1% (v/v) serum.  After washing with PBS-T, then four times in
PBS, the coverslips were mounted on glass slides and viewed using a BioRad MRC-1000
confocal microscope, Krypton-Argon laser, and Chroma 31002 (excitation 515-550 nm,
emission 575-615 nm) filters, and x60 oil objective.  The location of the ER in fixed freshly-
isolated rat hepatocytes in primary culture was determined using DiOC6(3) and confocal
microscopy as described previously [9].
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RESULTS
Effects of  Ins(1,4,6)P3, Ins(1,3,6)P3 and Ins(1,2,4,5)P4 on Ca
2+ inflow and release
The strategy employed was to use Ins(1,4,5)P3 analogues with different affinities for
Ins(1,4,5)P3R1 and Ins(1,4,5)P3R2 as probes for the involvement of each of these receptor
subtypes in the activation of SOCs.  The  analogues employed were  D-myo-Ins(1,4,6)P3 (higher
affinity for Ins(1,4,5)P3R1) and  D-myo-Ins(1,3,6)P3 and Ins(1,2,4,5)P4 (higher affinity for
Ins(1,4,5)P3R2) [21].  The abilities of D-myo-Ins(1,4,6)P3, Ins(1,3,6)P3 and Ins(1,2,4,5)P4, to
activate Ca2+ release and Ca2+ inflow  in rat hepatocytes were investigated by microinjecting
each analogue into hepatocytes together with fura-2.  The cells were incubated in the absence of
added Ca2+o, then Ca
2+
o was added (to allow an estimate of the rate of Ca
2+inflow) followed by
vasopressin (to release Ca2+ remaining in the intracellular stores).  It has previously been shown
that each of these analogues is resistant to metabolism by 5’-phosphatase and 3’-kinase activities
[31-34].  The results obtained for a high intracellular concentration (estimated to be 220 µM) of
Ins(1,3,6)P3 are shown in Figure 1A, and those for a control cell, microinjected with fura-2
alone, in Figure 1B.  The amount of Ca2+ released from the ER by the Ins(1,4,5)P3 analogue was
estimated by determining the difference between the Ca2+ released by vasopressin in the control
cell and that released by vasopressin in the cell loaded with the Ins(1,4,5)P3 analogue.  (The
rationale for this procedure is discussed in more detail in Materials and Methods.)
The dose-response curve for the effect of Ins(1,3,6)P3 on Ca
2+ release and Ca2+ inflow is
shown in Figure 2A.  This shows that the concentration of Ins(1,3,6)P3 which gave half-maximal
stimulation of Ca2+ inflow is substantially higher than that which gave half-maximal stimulation
of Ca2+ release.  A similar dose-response pattern but with less pronounced differences, was
observed with Ins(1,2,4,5)P4 (Figure 2B).  D-2-deoxy-Ins(1,4,5)P3 (higher affinity for
Ins(1,4,5)P3R2 than Ins(1,4,5)P3R1 [21]) was also tested.  However, the microinjection of D-2-
deoxy-Ins(1,4,5)P3 had no effect on either Ca
2+ release or Ca2+inflow, most likely due to its rapid
metabolism in liver cells [35].
In contrast to the results obtained with Ins(1,3,6)P3 and Ins(1,2,4,5)P4, when the experiment
was conducted with Ins(1,4,6)P3 (Figure 2C), the concentration of Ins(1,4,6)P3 which gave half-
maximal stimulation of Ca2+ inflow was found to be lower than that which gave half-maximal
stimulation of Ca2+ release.  Thus, relative to the ability to induce Ca2+ release, Ins(1,4,6)P3 is
more effective than Ins(1,3,6)P3 in inducing Ca
2+ inflow.
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Intracellular distribution of Ins(1,4,5)P3R1 and Ins(1,4,5)P3R2 under conditions employed
for the measurement of Ca2+ inflow
The intracellular locations of Ins(1,4,5)P3R1 and Ins(1,4,5)P3R2 were determined using
antibodies specific for these proteins and immunofluorescence.  The specificity of the antibodies
for Ins(1,4,5)P3R1 and Ins(1,4,5)P3R2 was confirmed by Western blot analysis using extracts of
L15 mouse fibroblasts [27], which express Ins(1,4,5)P3R1 but do not express significant levels of
Ins(1,4,5)P3R2 [29], and extracts of SaOS-2 human osteoblasts, which predominantly express
Ins(1,4,5)P3R2 and Ins(1,4,5)P3R3 [28].  A single band corresponding to the expected size of the
Ins(1,4,5)P3R was observed in each case (results not shown).  In extracts of rat liver, each
antibody also gave a single band corresponding to the expected size of the Ins(1,4,5)P3R1 or
Ins(1,4,5)P3R2 (results not shown).
In immunofluorescence experiments with hepatocytes cultured for 2 h under conditions
similar to those employed for the measurement of Ca2+ inflow and release, Ins(1,4,5)P3R1 was
principally located in a band at the cell periphery with little in the interior of the cytoplasmic
space, and none in the nucleus (Figure 3A).  Ins(1,4,5)P3R2 was also located in a clearly-defined
band at the cell periphery with some expression also in the cytoplasmic space (Figure 3B).  In
some experiments, labelling of the nucleus by anti-Ins(1,4,5)P3R2 was seen (results not shown).
Panels b, f and j of each of Figures 3A and 3B show equatorial sections from three representative
cells.  Images were also obtained at 3 µm above (panels c, g, k) and below (panels d, h, l) the
equatorial plane (the diameter of the cultured cells in the Z axis was 10-20 µm).  More intense
staining was observed for the images obtained 3 µm above the equatorial plane (closer to the
coverslip on which the cells were attached).
Freshly-isolated hepatocytes exhibit little polarity, but when attached to a collagen-coated
glass surface begin to regain polarity (assessed, for example, by formation of the cortical actin
cytoskeleton) after about 4 h in culture [15,36].  To determine whether re-polarisation affects the
intracellular distribution of Ins(1,4,5)P3R, the distribution of Ins(1,4,5)P3R2 was determined at 1
and 4 h after the initiation of cell culture.  Ins(1,4,5)P3R2 was studied because it gave a more
intense immunofluorescence signal than that generated by Ins(1,4,5)P3R1.  Images obtained in
the equatorial plane are shown in Figure 4.  There was a significant increase in total
immunofluorescence due to Ins(1,4,5)P3R2 at 4 h, possibly due to increased synthesis and/or
decreased degradation of Ins(1,4,5)P3R, although there was no change in the intracellular
distribution of Ins(1,4,5)P3R2 (Figure 4).
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The distribution of the ER in hepatocytes cultured under conditions similar to those employed
for the measurement of Ca2+ inflow was also determined using DiOC6(3).  The results indicate
that the ER is distributed throughout the cytoplasmic space and, at the periphery of the cell,
extends to the plasma membrane (results not shown, and [15]).
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DISCUSSION
The most interesting aspect of this study is the observation that the relationship between the
dose-response curves for Ca2+ inflow and Ca2+ release for each of Ins(1,3,6)P3 and Ins(1,2,4,5)P4
differs from that for Ins(1,4,6)P3.  Thus Ins(1,4,6)P3 which, on the basis of studies conducted
with Ins(1,4,5)P3R1 and Ins(1,4,5)P3R2 expressed in insect Sf9 cells [21], has a higher affinity for
Ins(1,4,5)P3R1 than Ins(1,4,5)P3R2, activated Ca
2+ inflow at lower concentrations than those
which induced significant Ca2+ release.  By contrast, Ins(1,3,6)P3 and Ins(1,2,4,5)P4, each of
which has a higher affinity for Ins(1,4,5)P3R2 than Ins(1,4,5)P3R1 [21], induced Ca
2+ release at
lower concentrations than those which activated substantial Ca2+ inflow.  These results suggest
that, in intact hepatocytes, the binding of Ins(1,4,5)P3 to Ins(1,4,5)P3R1s is more effective in
activating SOCs than the binding of Ins(1,4,5)P3 to Ins(1,4,5)P3R2s.
It is recognised that there are a number of assumptions made in interpretation of the dose-
response curves for Ins(1,4,5)P3 analogues reported here.  Firstly, the measured difference in
apparent affinity of a given analogue for Ins(1,4,5)P3R1 and Ins(1,4,5)P3R2 is relatively small
[21].  Secondly, it is assumed that Ins(1,3,6)P3 and Ins(1,4,6)P4 are resistant to metabolism
[33,34] and diffuse throughout the cytoplasmic space [37] so that the cytoplasmic concentration
of the Ins(1,4,5)P3 analogue remains approximately constant during the period over which Ca
2+
inflow and Ca2+ release are measured.  Thirdly, it was not possible to raise the intracellular
concentrations of Ins(1,3,6)P3 and Ins(1,2,4,5)P4 to saturate the Ins(1,4,5)P3R.  Fourthly, the
amount of Ca2+ released was estimated using a somewhat indirect strategy.  While these
assumptions appear valid, some caution should be exercised in interpreting the dose-response
curves.  Nevertheless, the difference in the patterns of the dose-response curves for analogues
with different affinities for Ins(1,4,5)P3R1 and Ins(1,4,5)P3R2 is quite striking.
Previously, the differences in affinities of Ins(1,3,6)P3, Ins(1,4,6)P3 and Ins(1,4,5)P3 for
Ins(1,4,5)P3Rs have been rationalised by comparing their molecular structures in diagrams which
align the phosphate groups of the three molecules [21,33,38].  Molecular docking experiments
using the recently published X-ray crystal structure [39] of the Ins(1,4,5)P3R1 binding domain
can be used to extend this model by suggesting how the relative affinities of Ins(1,4,6)P3 and
Ins(1,3,6)P3 for Ins(1,4,5)P3R1 may be related to their abilities to mimic Ins(1,4,5)P3 in the
context of the Ins(1,4,5)P3R1 binding site (Figure 5).  An equivalent crystal structure for an
Ins(1,4,5)P3R2 domain is not yet available, but it is interesting to note that the residues of
Ins(1,4,5)P3R1 that interact with Ins(1,4,5)P3 are all conserved in Ins(1,4,5)P3R2, with the
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exception that Gly-268 in Ins(1,4,5)P3R1 is replaced by leucine in the Ins(1,4,5)P3R2 sequence in
both the mouse [40] and rat [41] (reviewed in [42]) Ins(1,4,5)P3R2 sequences.  It is possible that
the replacement of glycine with the sterically bulky and hydrophobic leucine residue at this
position could influence the local environment at the Ins(1,4,5)P3R2 binding site, perhaps with
consequences for the relative affinities of Ins(1,4,5)P3, Ins(1,4,6)P3, Ins(1,3,6)P3 and also
Ins(1,2,4,5)P4.
Both Ins(1,4,5)P3R1 and Ins(1,4,5)P3R2 were found to be predominantly located at the
periphery of the cell in rat hepatocytes cultured under conditions similar to those employed for
the measurement of Ca2+ inflow (single cells attached to collagen-coated glass slides and
cultured for 2 h).  At this stage of culture the cells exhibit little polarity [15,36].  Some co-
location of Ins(1,4,5)P3R1 and Ins(1,4,5)P3R2 at the periphery of the cell may be due to the
formation of Ins(1,4,5)P3R1/Ins(1,4,5)P3R2 heterotetramers [44].  It is interesting to note that
while Ins(1,4,5)P3R1 and Ins(1,4,5)P3R2 were both found concentrated near the plasma
membrane in hepatocytes cultured for 2 h, the ER was found distributed throughout the
cytoplasmic space.  This suggests that, for cells in this in vitro condition, the majority of the ER
has a very low density of Ins(1,4,5)P3R.  Previous histochemical studies with freshly-isolated
hepatocytes (unpolarised), hepatocyte couplets (partially polarised) and hepatocytes in situ
(completely polarised) have shown that Ins(1,4,5)P3R1 is located principally near the plasma
membrane while Ins(1,4,5)P3R2 is located at the plasma membrane and bile canaliculus [17-19].
Moreover, Ins(1,4,5)P3R2 located around the bile canaliculus appear to be responsible for the
initiation of Ca2+ waves [17].  Studies employing subcellular fractionation and electron
microscopy have provided clear evidence that in liver cells some Ins(1,4,5)P3R1 are located in
regions of the ER which are closely associated with the plasma membrane through F-actin
[18,19].  The present immunofluorescent results showing Ins(1,4,5)P3R1 at the cell periphery are
consistent with these results.  Thus, the role of Ins(1,4,5)P3R1 in apparently selectively activating
Ca2+ inflow is associated with the location of Ins(1,4,5)P3R1 close to the plasma membrane.
Taken together, the present results with Ins(1,4,5)P3 analogues selective for either
Ins(1,4,5)P3R1 or Ins(1,4,5)P3R2, the previous results using an anti-Ins(1,4,5)P3R1 antibody to
inhibit Ins(1,4,5)P3 function and adenophostin A to activate Ca
2+ inflow [9], and the evidence
that some Ins(1,4,5)P3R1 are closely associated with the plasma membrane [18,19], suggest that,
in hepatocytes, the activation of SOCs requires the release of Ca2+ from a small region of the ER
close to the plasma membrane and enriched in Ins(1,4,5)P3R1.  The requirement for
Ins(1,4,5)P3R1 for the activation of SOCs in hepatocytes may simply reflect enrichment of those
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putative subregions of the ER involved in the activation of SOCs with Ins(1,4,5)P3R1.  It is
hypothesised here that the role of Ins(1,4,5)P3R1 is solely to mediate release of Ca
2+ from the ER.
At this stage there is no evidence for direct interaction between the Ins(1,4,5)P3R1 protein and
the SOC protein in hepatocytes.  In vivo, where the activation of SOCs is initiated by
Ins(1,4,5)P3 generated by the hormone-induced activation of phospholipase C, additional factors
will likely also influence the relative ability of Ins(1,4,5)P3 to activate SOCs and release
Ca2+from intracellular stores.  These include the rate of metabolism of Ins(1,4,5)P3 [6], the
effects of Ca2+ on the affinity of Ins(1,4,5)P3 for Ins(1,4,5)P3Rs [45] and the locations of
hormone receptors and phospholipase C in relation to that of Ins(1,4,5)P3Rs [46,47].
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LEGENDS TO FIGURES
Figure 1     Effects of Ins(1,3,6)P3 on Ca
2+ inflow and the vasopressin-induced increase in
[Ca2+]cyt in single rat hepatocytes
Single hepatocytes were injected with fura-2 plus 220 µM Ins(1,3,6)P3 (estimated intracellular
concentration) (A) or fura-2 alone (B) 10 min before beginning the measurement of
fluorescence.  Additions of Ca2+ (1.5 mM) and vasopressin (40 nM) were made as indicated by
the horizontal bars.  Each trace is representative of those obtained for 21-97 individual cells from
2-7 separate hepatocyte preparations.
Figure 2     Comparison of concentration-response curves for the effects of Ins(1,3,6)P3,
Ins(1,2,4,5)P4 and Ins(1,4,6)P3 on the release of Ca
2+ from intracellular stores and on Ca2+
inflow
Ins(1,3,6)P3 (A), Ins(1,2,4,5)P4 (B) or Ins(1,4,6)P3 (C) was co-injected into single hepatocytes
with fura-2 10 min before beginning the measurement of fluorescence, and Ca2+ and vasopressin
were added to the incubation medium as described in Figure 1.  Rates of Ca2+ inflow () and
amounts of Ca2+ release (z) were estimated as described in Materials and Methods.  Each data
point is the mean ± S.E.M. of the values obtained from 17-97 individual hepatocytes from 1-7
separate hepatocyte preparations.
Figure 3     Localisation by immunofluorescence of the type I (A) and type II (B)
Ins(1,4,5)P3 receptors in rat hepatocytes grown for 2 h in primary culture
The culture of rat hepatocytes, permeabilisation and cell fixation, staining with anti-Ins(1,4,5)P3
antibody, and confocal microscopy were performed as described in Materials and Methods.  (A)
Cells stained with mouse monoclonal anti-Ins(1,4,5)P3R1 antibody KM1112 and anti-mouse
antibody conjugated to Cy3.  (B) Cells stained with mouse monoclonal anti-Ins(1,4,5)P3R2
antibody KM1083 and anti-mouse antibody conjugated to Cy3.  The results shown are those
obtained for one of 3 experiments employing 3 separate rat hepatocyte preparations which each
gave similar results.  The scale bar represents 10 µm.  Panels (a-d), (e-h) and (i-l) each represent
a different single cell, showing bright field image, equatorial image, 3 µm above equatorial
image (Z plane) and 3 µm below equatorial, respectively.  Panels (m) and (n) are controls in
which primary antibody has been omitted.  All images in A and B were obtained with the same
confocal gain setting.
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Figure 4    Localisation by immunofluorescence of the type II Ins(1,4,5)P3 receptor in rat
hepatocytes grown for 1 and 4 h in primary culture
The culture of rat hepatocytes, permeabilisation and cell fixation, staining with anti-Ins(1,4,5)P3
antibody, and confocal microscopy were performed as described in Materials and Methods.
Cells were stained with mouse monoclonal anti-Ins(1,4,5)P3R2 antibody KM1083 and anti-
mouse antibody conjugated to Cy3.  The results shown are those obtained for one of 3
experiments employing 3 separate rat hepatocyte preparations which each gave similar results.
The scale bar represents 10 µm.  Panels a-f represent different cells showing the bright field
images (a, c, e) and immunofluorescence (equatorial sections) (b, d, f) for cells cultured at 1 h.
Panels h-m represent different cells showing the bright field images (h, j, l) and
immunofluorescence (equatorial sections) (i, k, m) for cells cultured at 4 h.  Panels g and n are
controls in which the primary antibody has been omitted.
Figure 5    Structure of the Ins(1,4,5)P3R1 binding site based on the x-ray crystal structure
of the mouse Ins(1,4,5)P3R1 core binding domain
The crystallographically-observed position of bound Ins(1,4,5)P3 [39] is shown in orange.
Molecular docking experiments suggest that Ins(1,4,6)P3 (green) may be a relatively effective
mimic of Ins(1,4,5)P3 at the Ins(1,4,5)P3R1 binding site because it can bind in an orientation that
allows its phosphate groups to mimic the three phosphate groups of Ins(1,4,5)P3, while its axial
2-hydroxyl group is accepted by an open region close to Gly-268.  However, Ins(1,3,6)P3
(purple) may be prevented from adopting a similar binding mode due to unfavourable steric
interactions of its axial 2-hydroxyl group with Arg-568 and Lys-569.  Molecular docking
experiments were carried out using the X-ray crystal structure of the Ins(1,4,5)P3-binding core of
mouse type 1 InsP3R in complex with Ins(1,4,5)P3 (1N4K [39]) according to methods previously
described [43].  For clarity, six molecules of water included in the docking experiments and the
hydrogen atoms of Ins(1,4,5)P3, Ins(1,4,6)P3 and Ins(1,3,6)P3 are not shown.
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